BRPI0922664A2 - derivados de imidazol bicílicos substituídos como moduladores de gama secretase - Google Patents

derivados de imidazol bicílicos substituídos como moduladores de gama secretase

Info

Publication number
BRPI0922664A2
BRPI0922664A2 BRPI0922664A BRPI0922664A BRPI0922664A2 BR PI0922664 A2 BRPI0922664 A2 BR PI0922664A2 BR PI0922664 A BRPI0922664 A BR PI0922664A BR PI0922664 A BRPI0922664 A BR PI0922664A BR PI0922664 A2 BRPI0922664 A2 BR PI0922664A2
Authority
BR
Brazil
Prior art keywords
imidazole derivatives
gamma secretase
substituted bicyclic
secretase modulators
bicyclic imidazole
Prior art date
Application number
BRPI0922664A
Other languages
English (en)
Inventor
Andrés Avelino Trabanco-Suarez
Didier Jean-Claude Berthelot
François Paul Bischoff
Gary John Tresadern
Greogor James Macdonald
Henricus Jacobus Maria Gijsen
Sven Franciscus Anna Brandt
Original Assignee
Ortho Mcneil Janssen Pharm
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ortho Mcneil Janssen Pharm filed Critical Ortho Mcneil Janssen Pharm
Publication of BRPI0922664A2 publication Critical patent/BRPI0922664A2/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D455/00—Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine
    • C07D455/02—Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine containing not further condensed quinolizine ring systems
BRPI0922664A 2008-12-18 2009-12-16 derivados de imidazol bicílicos substituídos como moduladores de gama secretase BRPI0922664A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP08172202 2008-12-18
PCT/EP2009/067321 WO2010070008A1 (en) 2008-12-18 2009-12-16 Substituted bicyclic imidazole derivatives as gamma secretase modulators

Publications (1)

Publication Number Publication Date
BRPI0922664A2 true BRPI0922664A2 (pt) 2016-01-05

Family

ID=40451180

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0922664A BRPI0922664A2 (pt) 2008-12-18 2009-12-16 derivados de imidazol bicílicos substituídos como moduladores de gama secretase

Country Status (21)

Country Link
US (1) US8546440B2 (pt)
EP (1) EP2379552B1 (pt)
JP (2) JP2012512831A (pt)
KR (1) KR20110102455A (pt)
CN (1) CN102256974B (pt)
AP (1) AP2011005692A0 (pt)
AR (1) AR074771A1 (pt)
AU (1) AU2009327103B2 (pt)
BR (1) BRPI0922664A2 (pt)
CA (1) CA2742914A1 (pt)
EA (1) EA018625B1 (pt)
ES (1) ES2460642T3 (pt)
IL (1) IL213563A (pt)
MX (1) MX2011006543A (pt)
NZ (1) NZ594036A (pt)
PA (1) PA8854101A1 (pt)
SG (1) SG172213A1 (pt)
TW (1) TWI438203B (pt)
UA (1) UA104151C2 (pt)
WO (1) WO2010070008A1 (pt)
ZA (1) ZA201104504B (pt)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7868001B2 (en) * 2007-11-02 2011-01-11 Hutchison Medipharma Enterprises Limited Cytokine inhibitors
BRPI0921317A2 (pt) 2008-11-06 2017-06-06 Astrazeneca Ab composto, composição farmacêutica, e, método para tratar ou prevenir uma patologia relacionada com abeta em um mamífero
PA8854101A1 (es) 2008-12-18 2010-07-27 Ortho Mcneil Janssen Pharm Derivados de imidazol bicíclicos sustituidos como moduladores de gamma secretasa
AP2011005779A0 (en) 2009-02-06 2011-08-31 Ortho Mcneil Janssen Pharm Novel susbstituted bicyclic heterocyclic compoundsas gamma secretase modulators.
TWI461425B (zh) 2009-02-19 2014-11-21 Janssen Pharmaceuticals Inc 作為伽瑪分泌酶調節劑之新穎經取代的苯并唑、苯并咪唑、唑并吡啶及咪唑并吡啶衍生物類
NZ596843A (en) 2009-05-07 2012-12-21 Janssen Pharmaceuticals Inc Novel substituted indazole and aza-indazole derivatives as gamma secretase modulators
TWI598347B (zh) 2009-07-13 2017-09-11 基利科學股份有限公司 調節細胞凋亡信號之激酶的抑制劑
EP2454239B1 (en) 2009-07-15 2014-08-13 Janssen Pharmaceuticals Inc. Substituted triazole and imidazole derivatives as gamma secretase modulators
BR112012017310A2 (pt) 2010-01-15 2016-04-19 Janssen Pharmaceuticals Inc derivados de triazol substituídos como moduladores de gama secretase
WO2012013713A2 (en) 2010-07-28 2012-02-02 Bayer Pharma Aktiengesellschaft Substituted imidazo[1,2-b]pyridazines
KR20140047032A (ko) 2011-03-24 2014-04-21 얀센 파마슈티칼즈, 인코포레이티드 감마 세크레타제 조정제로서의 신규 치환 트리아졸릴 피페라진 및 트리아졸릴 피페리딘 유도체
WO2012131539A1 (en) 2011-03-31 2012-10-04 Pfizer Inc. Novel bicyclic pyridinones
ES2545135T3 (es) 2011-04-06 2015-09-08 Bayer Pharma Aktiengesellschaft Imidazopiridinas sustituidas y compuestos intermedios de las mismas
HUE026323T2 (en) 2011-04-07 2016-05-30 Bayer Ip Gmbh Imidazopyridazines as AKT kinase inhibitors
IN2014MN00258A (pt) 2011-07-15 2015-09-25 Janssen Pharmaceuticals Inc
AU2012325909B2 (en) 2011-10-20 2016-06-09 Glaxosmithkline Llc Substituted bicyclic aza-heterocycles and analogues as sirtuin modulators
EP2768833A4 (en) * 2011-10-20 2015-04-15 Sirtris Pharmaceuticals Inc SUBSTITUTED BICYCLIC AZA-HETEROCYCLES AND ANALOGUES AS MODULATORS OF SIRTUINS
WO2013064445A1 (en) * 2011-11-01 2013-05-10 F. Hoffmann-La Roche Ag Imidazopyridazine compounds
CN104159891B (zh) 2012-01-10 2016-09-07 霍夫曼-拉罗奇有限公司 哒嗪酰胺化合物和它们作为syk 抑制剂的用途
AU2013261023B2 (en) 2012-05-16 2016-11-24 Cellzome Limited Substituted 3, 4 - dihydro - 2H - pyrido [1, 2 -a] pyrazine - 1, 6 - dione derivatives useful for the treatment of (inter alia) Alzheimer's disease
FR2993564B1 (fr) 2012-07-20 2014-08-22 Metabrain Res Derives d'imidazopyridine utiles dans le traitement du diabete
UA110688C2 (uk) 2012-09-21 2016-01-25 Пфайзер Інк. Біциклічні піридинони
CA2889249C (en) 2012-12-20 2021-02-16 Francois Paul Bischoff Tricyclic 3,4-dihydro-2h-pyrido[1,2-a]pyrazine-1,6-dione derivatives as gamma secretase modulators
EP2945944B1 (en) 2013-01-17 2016-11-09 Janssen Pharmaceutica, N.V. Novel substituted pyrido-piperazinone derivatives as gamma secretase modulators
BR112015030678A8 (pt) * 2013-06-12 2020-01-07 Janssen Pharmaceutica Nv derivados 4-amino-6-fenil-5,6-di-hidroimidazo [1,5-a] pirazina como inibidores de beta-secretase (bace), composição farmacêutica, processo para preparação da mesma, e usos na fabricação de medicamentos
EA032662B1 (ru) * 2013-06-12 2019-06-28 Янссен Фармацевтика Нв ПРОИЗВОДНЫЕ 4-АМИНО-6-ФЕНИЛ-5,6-ДИГИДРОИМИДАЗО[1,5-а]ПИРАЗИН-3(2H)-ОНА В КАЧЕСТВЕ ИНГИБИТОРОВ БЕТА-СЕКРЕТАЗЫ (BACE)
US10562897B2 (en) 2014-01-16 2020-02-18 Janssen Pharmaceutica Nv Substituted 3,4-dihydro-2H-pyrido[1,2-a]pyrazine-1,6-diones as gamma secretase modulators
WO2015166370A1 (en) 2014-04-28 2015-11-05 Pfizer Inc. Heteroaromatic compounds and their use as dopamine d1 ligands
ES2768823T3 (es) 2014-12-18 2020-06-23 Janssen Pharmaceutica Nv Derivados de 2,3,4,5-tetrahidropiridin-6-amina y 3,4-dihidro-2H-pirrol-5-amina útiles como inhibidores de beta-secretasa
CA3202893A1 (en) * 2014-12-23 2016-06-30 Gilead Science, Inc. Processes for preparing ask1 inhibitors
MA41252A (fr) 2014-12-23 2017-10-31 Gilead Sciences Inc Formes solides d'un inhibiteur d'ask 1
MX368391B (es) 2015-02-03 2019-09-30 Pfizer Ciclopropabenzofuranil-piridopirazindionas novedosas.
CN107743486B (zh) * 2015-03-12 2021-04-09 Fmc公司 杂环取代的二环唑杀有害生物剂
ES2955596T3 (es) * 2018-10-05 2023-12-04 Corteva Agriscience Llc Proceso e intermedios para la preparación de determinadas sulfonamidas nematicidas

Family Cites Families (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU5702201A (en) 2000-04-13 2001-10-30 Mayo Foundation Abeta<sub>42</sub> lowering agents
DE10238002A1 (de) 2002-08-20 2004-03-04 Merck Patent Gmbh Benzimidazolderivate
AU2004247013B2 (en) 2003-05-14 2010-07-08 Neurogenetic Pharmaceuticals, Inc. Compounds and uses thereof in modulating amyloid beta
DE602005023965D1 (de) 2004-03-08 2010-11-18 Prosidion Ltd Pyrrolopyridin-2-carbonsäurehydrazide als inhibitoren von glykogenphosphorylase
KR101128065B1 (ko) 2004-05-26 2012-04-12 에자이 알앤드디 매니지먼트 가부시키가이샤 신나미드 화합물
AU2005297966B2 (en) 2004-10-26 2010-12-23 Eisai R & D Management Co., Ltd. Amorphous object of cinnamide compound
US7572807B2 (en) 2005-06-09 2009-08-11 Bristol-Myers Squibb Company Heteroaryl 11-beta-hydroxysteroid dehydrogenase type I inhibitors
US20070078136A1 (en) * 2005-09-22 2007-04-05 Bristol-Myers Squibb Company Fused heterocyclic compounds useful as kinase modulators
WO2007043786A1 (en) * 2005-10-10 2007-04-19 Seiyang Yang Dynamic-based verification apparatus for verification from electronic system level to gate level, and verification method using the same
EP1937767B1 (en) 2005-10-11 2013-05-22 Chemtura Corporation Diaromatic amines
US20090163482A1 (en) 2006-03-13 2009-06-25 Mchardy Stanton Furst Tetralines antagonists of the h-3 receptor
GB0606774D0 (en) 2006-04-03 2006-05-10 Novartis Ag Organic compounds
US7893058B2 (en) * 2006-05-15 2011-02-22 Janssen Pharmaceutica Nv Imidazolopyrazine compounds useful for the treatment of degenerative and inflammatory diseases
US7951818B2 (en) * 2006-12-01 2011-05-31 Galapagos Nv Imidazolopyridine compounds useful for the treatment of degenerative and inflammatory diseases
WO2008082490A2 (en) * 2006-12-20 2008-07-10 Schering Corporation Novel jnk inhibitors
AU2008214372A1 (en) 2007-02-08 2008-08-14 Merck Sharp & Dohme Corp. Therapeutic agents
RU2009144998A (ru) * 2007-05-07 2011-06-20 Шеринг Корпорейшн (US) Модуляторы гамма-секретазы
BRPI0811993A2 (pt) 2007-05-11 2014-11-18 Hoffmann La Roche " hetarilanilinas como moduladores para beta-amiloide ".
EP2166854A4 (en) 2007-06-13 2012-05-16 Merck Sharp & Dohme TRIAZOLE DERIVATIVES FOR THE TREATMENT OF ALZHEIMER'S DISEASE AND ASSOCIATED STATES
WO2009005729A1 (en) 2007-06-29 2009-01-08 Schering Corporation Gamma secretase modulators
US7935815B2 (en) 2007-08-31 2011-05-03 Eisai R&D Management Co., Ltd. Imidazoyl pyridine compounds and salts thereof
CA2698341A1 (en) 2007-09-06 2009-03-12 Schering Corporation Gamma secretase modulators
JP2011502244A (ja) 2007-10-19 2011-01-20 エラック エイエス Ｅｄｔａ耐性ｓ１００ａ１２複合体（ｅｒａｃ）
KR20100094554A (ko) 2007-12-06 2010-08-26 쉐링 코포레이션 감마 세크레타제 조절인자
WO2009076352A1 (en) 2007-12-11 2009-06-18 Schering Corporation Gamma secretase modulators
CA2713716A1 (en) 2008-02-22 2009-08-27 F. Hoffmann-La Roche Ag Modulators for amyloid beta
WO2010010188A1 (en) 2008-07-25 2010-01-28 Galapagos Nv Novel compounds useful for the treatment of degenerative and inflammatory diseases.
US20120129846A1 (en) * 2008-11-06 2012-05-24 Zhaoning Zhu Gamma secretase modulators
CA2744152A1 (en) 2008-12-03 2010-06-10 Via Pharmaceuticals, Inc. Inhibitors of diacylglycerol acyltransferase
PA8854101A1 (es) 2008-12-18 2010-07-27 Ortho Mcneil Janssen Pharm Derivados de imidazol bicíclicos sustituidos como moduladores de gamma secretasa
TW201030002A (en) 2009-01-16 2010-08-16 Bristol Myers Squibb Co Bicyclic compounds for the reduction of beta-amyloid production
AP2011005779A0 (en) 2009-02-06 2011-08-31 Ortho Mcneil Janssen Pharm Novel susbstituted bicyclic heterocyclic compoundsas gamma secretase modulators.
TWI461425B (zh) 2009-02-19 2014-11-21 Janssen Pharmaceuticals Inc 作為伽瑪分泌酶調節劑之新穎經取代的苯并唑、苯并咪唑、唑并吡啶及咪唑并吡啶衍生物類
JP2012051806A (ja) 2009-02-26 2012-03-15 Eisai R & D Management Co Ltd イミダゾリルピラジン誘導体
EP2424866A1 (en) 2009-04-27 2012-03-07 High Point Pharmaceuticals, LLC Substituted imidazo[1,2-a]pyridine derivatives, pharmaceutical compositions, and methods of use as -secretase inhibitors
NZ596843A (en) 2009-05-07 2012-12-21 Janssen Pharmaceuticals Inc Novel substituted indazole and aza-indazole derivatives as gamma secretase modulators
JP2010274429A (ja) 2009-05-26 2010-12-09 Ihi Corp アライメントステージ
EP2454239B1 (en) 2009-07-15 2014-08-13 Janssen Pharmaceuticals Inc. Substituted triazole and imidazole derivatives as gamma secretase modulators

Also Published As

Publication number Publication date
JP2015164969A (ja) 2015-09-17
KR20110102455A (ko) 2011-09-16
US20110237580A1 (en) 2011-09-29
UA104151C2 (ru) 2014-01-10
TW201035093A (en) 2010-10-01
JP2012512831A (ja) 2012-06-07
AR074771A1 (es) 2011-02-09
SG172213A1 (en) 2011-07-28
US8546440B2 (en) 2013-10-01
IL213563A0 (en) 2011-07-31
NZ594036A (en) 2012-10-26
CA2742914A1 (en) 2010-06-24
PA8854101A1 (es) 2010-07-27
AU2009327103B2 (en) 2014-12-04
EA018625B1 (ru) 2013-09-30
TWI438203B (zh) 2014-05-21
EP2379552B1 (en) 2014-02-26
WO2010070008A1 (en) 2010-06-24
MX2011006543A (es) 2011-07-20
EP2379552A1 (en) 2011-10-26
AP2011005692A0 (en) 2011-06-30
CN102256974A (zh) 2011-11-23
CN102256974B (zh) 2014-07-30
ES2460642T3 (es) 2014-05-14
EA201170829A1 (ru) 2011-12-30
IL213563A (en) 2015-06-30
ZA201104504B (en) 2014-01-29
AU2009327103A1 (en) 2011-07-21

Similar Documents

Publication Publication Date Title
BRPI0922664A2 (pt) derivados de imidazol bicílicos substituídos como moduladores de gama secretase
BR112012000915A2 (pt) derivados de triazol e imidazol substituídos como moduladores de gama secretase.
BRPI0921348A2 (pt) moduladores heterocíclicos da gama secretase
ZA201105788B (en) Novel substituted bicyclic heterocyclic compounds as gamma secretase modulators
ZA201205245B (en) Novel substituted bicyclic triazole derivatives as gamma secretase modulators
BR112012010502A2 (pt) derivados de benzimidazol-imidazol
BRPI0817609A2 (pt) Derivados de imidazol
BRPI0814403A2 (pt) Devirados de imidazol como antagonistas de receptor ccr2
BRPI0909157A2 (pt) compostos heterocíclicos como antagonistas de receptores de adenosina
BRPI1016120A2 (pt) derivados de benzoxazol, benzimidazol, oxazolopiridina e imidazopiridina substituídos como moduladores de gama secretase.
BRPI0906625A2 (pt) Derivados de tio-2-amino-quinolina-6-substituída úteis como inibidores da beta-secretase (bace)
BR112013012378A2 (pt) derivados de imidazol como inibidores de enzima pde10a
BRPI0913580A2 (pt) pirrolopiridinas como inibidores de quinase
CO6862146A2 (es) Derivados fusionados de imidazol usados como inhibidores de ido
BRPI0908849A2 (pt) Composto e composições como c-kit e inibidores de pdgfr quinase
BRPI0911347A2 (pt) gama lactamas substituídas como agentes terapêuticos
BRPI0818855A2 (pt) Derivados de imidazol
HK1158638A1 (en) Bridged bicyclic heteroaryl substituted triazoles useful as axl inhibitors
BRPI0812170A2 (pt) Moduladores de gama secretase
BRPI0920135A2 (pt) imidazopiridazinacarbonitrilos úteis como inibidores de quinase
BRPI0912234A2 (pt) derivados de salinosporamida como inibidores de proteassomas
BRPI0922799A2 (pt) lactamas como inibidores da beta secretase
BRPI0813768A2 (pt) Derivados de benzazepina úteis como antagonistas de vasopressina
BRPI0914301A2 (pt) derivados de pirimidin-4-ona substituída
BRPI0920247A2 (pt) benzimidazóis heterocíclicos como moduladores de trpm8.

Legal Events

Date Code Title Description
B25D Requested change of name of applicant approved

Owner name: JANSSEN PHARMACEUTICALS, INC. (US)

B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 7A ANUIDADE.

B25A Requested transfer of rights approved

Owner name: CELLZOME LIMITED (GB) , JANSSEN PHARMACEUTICALS, I

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]